1.
Wollenberg A, Guttman-Yassky E, Torpet M, Silverberg JI. Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. J of Skin [Internet]. 2018Dec.17 [cited 2024Sep.20];2:S63. Available from: https://dermsquared.com/skin/article/view/459